| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | LEON Closes Funding Round for Nanoparticle Manufacturing Scale-Up | ||
| 12.02. | Iterative Health Adds Nadege Gunn as CMO, Hepatology and Obesity | ||
| 12.02. | Trenchant BioSystems, Invetech Sign Nonbinding Pact to Advance Automated CGT Manufacturing Platform | ||
| 12.02. | Alkermes Acquires Avadel Pharmaceuticals | ||
| 11.02. | Syngene, Johns Hopkins Unite to Advance Early-Stage Drug Discovery | ||
| 11.02. | Rentschler Biopharma Names Veit Bergendahl COO | ||
| 11.02. | Thermo Fisher, Datavant to Partner on Linking Real-World Data to Clinical Research | ||
| 11.02. | PL BioScience Wins Regulatory Certification from Japan's PMDA | ||
| 11.02. | FUJIFILM Biotechnologies Expands in the UK | ||
| 09.02. | Waters Completes Combination With BD Biosciences, Diagnostic Solutions Businesses | ||
| 09.02. | Bruker Introduces Label-Free Characterization Platform for Nanoscale Bioparticles | ||
| 09.02. | Bristol Myers Squibb 4Q Results | ||
| 09.02. | Innovent and Lilly's Seventh Collaboration Sets Model to Accelerate Pipeline Development | ||
| 09.02. | PharmaEssentia to Establish a Manufacturing Subsidiary in Puerto Rico | ||
| 09.02. | Fresenius Kabi, Phlow Partner to Onshore the Manufacture of Epinephrine Injection in the U.S. | ||
| 09.02. | Eurofins Viracor BioPharma Services Expands Service Portfolio | ||
| 06.02. | Samsung Biologics Product Carbon Footprint System Validated by Third Party | ||
| 06.02. | Lilly 4Q Results | ||
| 06.02. | Eisai, Henlius Strike Japan Commercialization Deal for PD-1 Antibody Serplulimab | ||
| 06.02. | FDA Grants Priority Review for Pfizer's HYMPAVZI | ||
| 05.02. | Pfizer 4Q Results | ||
| 05.02. | ADARx Pharmaceuticals Appoints Donald Fong as CMO | ||
| 05.02. | Sanofi 4Q Results | ||
| 05.02. | Braveheart Bio Promotes CSO, Names New SVP | ||
| 05.02. | AbbVie Submits Regulatory Applications for Rinvoq in Patients with Vitiligo |